Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions. CETP has no preference for cholesteryl esters in HDL versus LDL

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 718-726

  Serdyuk, Anatole P ^a,b   Morton, Richard E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

Author keywords

Cholesteryl ester; Cholesteryl ester transfer protein; Heteroexchange; Lipid transfer inhibitor protein; Lipoprotein preference

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; INHIBITOR PROTEIN; LOW DENSITY LIPOPROTEIN;

ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HUMAN; LIPID ANALYSIS; LIPID TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LIPID INTERACTION;

EID: 0033013273     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.718     Document Type: Article

References (61)

1. Morton RE. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes. Experientia. 1990;46:552-560.
2. Tall A. Plasma lipid transfer proteins. Annu Rev Biochem. 1995;64: 235-257.
3. Zechner R, Dieplinger H, Steyrer E, Groener J, Calvert D, Kostner GM. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin-cholesterol acyltransferase and cholesterol ester transfer protein. Biochim Biophys Acta. 1987;918:27-35.
4. Ellsworth JL, Kashyap ML, Jackson RL, Harmony JAK. Human plasma lipid transfer protein catalyzes the speciation of high density lipoproteins. Biochim Biophys Acta. 1987;918:260-266.
5. Deckelbaum RJ, Eisenberg S, Oschry Y, Granot E, Sharon I, Bengtsson-Olivecrona G. Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3: Roles of neutral lipid exchange and triglyceride lipases. J Biol Chem. 1986;261:5201-5208.
6. Liang H-Q, Rye K-A, Barter PJ. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. J Lipid Res. 1994;35:1187-1199.
7. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993;34: 1255-1274.
8. Morton RE. Interaction of plasma-derived lipid transfer protein with macrophages in culture. J Lipid Res. 1988;29:1367-1377.
9. Chait A, Eisenberg S, Steinmetz A, Albers JJ, Bierman EL. Low-density lipoproteins modified by lipid transfer protein have altered biological activity. Biochim Biophys Acta. 1984;795:314-325.
10. Kinoshita M, Krul ES, Schonfeld G. Modification of the core lipids of low density lipoproteins produces selective alterations in the expression of apoB-100 epitopes. J Lipid Res. 1990;31:701-708.
11. Deckelbaum RJ, Eisenberg S, Oschry Y, Rudel LL. Neutral lipid transfer and lipolysis convert high molecular weight LDL from cholesterol-fed nonhuman primates towards normal: a molecular analysis. Biochim Biophys Acta. 1988;961:223-233.
12. Lagrost L, Gambert P, Lallemant C. Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb. 1994;14:1327-1336.
13. Viens L, Lagrost L. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins. J Lipid Res. 1997;38:1129-1138.
14. Deckelbaum RJ, Eisenberg S, Fainaru M, Barenholz Y, Olivecrona T. In vitro production of human plasma low density lipoprotein-like particles: A model for very low density lipoprotein catabolism. J Biol Chem. 1979;254:6079-6087.
15. Ohta T, Nakamura R, Takata K, Saito Y, Yamashita S, Horiuchi S, Matsuda I. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J Lipid Res. 1995;36:696-704.
16. Ikewaki K, Nishiwaki M, Sakamoto T, Ishikawa T, Fairwell T, Zech LA, Nagano M, Nakamura H, Brewer HB, Jr, Rader DJ. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. J Clin Invest. 1995;96:1573-1581.
17. Francone OL, Royer L, Haghpassand M. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. J Lipid Res. 1996;37:1268-1277.
18. Tall A, Sharp D, Zhong S, Hayek T, Masucci-Magoulas L, Rubin EM, Breslow JL. Cholesteryl ester transfer protein and atherogenesis. Ann NY Acad Sci. 1997;811:178-184.
19. Morton RE, Zilversmit DB. A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. J Biol Chem. 1981;256:11992-11995.
20. Son Y-SC, Zilversmit DB. Purification and characterization of human plasma proteins that inhibit transfer activities. Biochim Biophys Acta. 1984;795:473-480.
21. Tollefson JH, Liu A, Albers JJ. Regulation of plasma lipid transfer by the high-density lipoproteins. Am J Physiol. 1988;255:E894-E902.
22. Nishide T, Tollefson JH, Albers JJ. Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein. J Lipid Res. 1989;30:149-158.
23. Morton RE, Greene DJ. Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: Selective inhibition among lipoprotein classes. J Lipid Res. 1994;35:836-847.
24. Morton RE, Steinbrunner JV. Determination of lipid transfer inhibitor protein activity in human lipoprotein-deficient plasma. Arterioscler Thromb. 1993;13:1843-1851.
25. Morton RE. Binding of plasma-derived lipid transfer protein to lipoprotein substrates: The role of binding in the lipid transfer process. J Biol Chem. 1985;260:12593-12599.
26. Tall AR. Plasma lipid transfer proteins. J Lipid Res. 1986;27:361-367.
27. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 1991;88: 2059-2066.
28. Murakami T, Michelagnoli S, Longhi R, Gianfranceschi G, Pazzucconi F, Calabresi L, Sirtori CR, Franceschini G. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol. 1995;15:1819-1828.
29. Tall A, Sammett D, Granot E. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest. 1986;77: 1163-1172.
30. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadzki Z, Weech PK, Whitlock ME, Tall AR, Milne RW. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest. 1990;85:10-17.
31. Cheung MC, Wolf AC, Lum KD, Tollefson JH, Albers JJ. Distribution and localization of lecithin: cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. J Lipid Res. 1986; 27:1135-1144.
32. Moulin P, Cheung MC, Bruce C, Zhong S, Cocke T, Richardson H, Tall AR. Gender effects on the distribution of the cholesteryl ester transfer protein in apolipoprotein A-I-defined lipoprotein subpopulations. J Lipid Res. 1994;35:793-802.
33. Speijer H, Groener JEM, Van Ramshorst E. Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis. 1991;90:159-168.
34. Nishida HI, Arai H, Nishida T. Cholesterol ester transfer mediated by lipid transfer protein as influenced by changes in the charge characteristics of plasma lipoproteins. J Biol Chem. 1993;268:16352-16360.
35. Sammett D, Tall AR. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem. 1985;260:6687-6697.
36. Pattnaik NM, Zilversmit DB. Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles. J Biol Chem. 1979;254:2782-2786.
37. Barter PJ, Hopkins GJ, Calvert GD. Transfers and exchanges of esterified cholesterol between plasma lipoproteins. Biochem J. 1982;208:1-7.
38. Yen FT, Deckelbaum RJ, Mann CJ, Marcel YL, Milne RW, Tall AR. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest. 1989;83:2018-2024.
39. Serdyuk AP, Morton RE. Lipid transfer inhibitor protein activity deficiency in normolipidemic uremic patients on continuous ambulatory peritoneal dialysis. Arterioscler Thromb Vasc Biol. 1997;17:1716-1724.
40. Morton RE, Zilversmit DB. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J Lipid Res. 1982;23:1058-1067.
41. Pattnaik NM, Montes A, Hughes LB, Zilversmit DB. Cholesteryl ester exchange protein in human plasma: Isolation and characterization. Biochim Biophys Acta. 1978;530:428-438.
42. Morton RE, Zilversmit DB. The separation of apolipoprotein D from cholesteryl ester transfer protein. Biochim Biophys Acta. 1981;663: 350-355.
43. Albers JJ, Tollefson JH, Chen C-H, Steinmetz A. Isolation and characterization of human lipid transfer proteins. Arteriosclerosis. 1984;4: 49-58.
44. Tollefson JH, Ravnik S, Albers JJ. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res. 1988;29:1593-1602.
45. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
46. Morton RE, Steinbrunner JV. Concentration of neutral lipids in the phospholipid surface of substrate particles determines lipid transfer protein activity. J Lipid Res. 1990;31:1559-1567.
47. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
48. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977;83:346-356.
49. Zak B, Moss N, Boyle AJ, Zlatkis A. Reactions of certain unsaturated steroids with acid iron reagent. Anal Chem. 1954;26:776-777.
50. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234:466-468.
51. Morton RE, Greene DJ. Enhanced detection of lipid transfer inhibitor protein activity by an assay involving only low density lipoprotein. J Lipid Res. 1994;35:2094-2099.
52. Morton RE. Specificity of lipid transfer protein for molecular species of cholesteryl ester. J Lipid Res. 1986;27:523-529.
53. Nichols AV, Smith L. Effect of very low-density lipoproteins on lipid transfer in incubated serum. J Lipid Res. 1965;6:206-210.
54. Holmquist L, Carlson LA. Net lipid transfer between lipoproteins in fish-eye disease plasma supplemented with normal high density lipoproteins. Lipids. 1987;22:305-311.
55. Morton RE, Zilversmit DB. Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J Biol Chem. 1983;258:11751-11757.
56. Ko KWS, Ohnishi T, Yokoyama S. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein. Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies. J Biol Chem. 1994; 269:28206-28213.
57. Channon KM, Clegg RJ, Bhatnagar D, Ishola M, Arrol S, Durrington PN. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis. 1990;80:217-226.
58. Van Tol A, Scheek LM, Groener JEM. Net mass transfer of cholesteryl esters from low density lipoproteins to high density lipoproteins in plasma from normolipidemic subjects. Arterioscler Thromb. 1991;11:55-63.
59. Liu XQ, Bagdade JD. Neutral lipid mass transfer among lipoproteins in plasma from normolipidemic subjects is not an equimolar heteroexchange. J Lipid Res. 1995;36:2574-2579.
60. Barter PJ, Chang LBF, Rajaram OV. Sodium oleate dissociates the heteroexchange of cholesteryl esters and triacylglycerol between HDL and triacylglycerol-rich lipoproteins. Biochim Biophys Acta. 1990;1047: 294-297.
61. Kane JP, Sata T, Hamilton RL, Havel RJ. Apoprotein composition of very low density lipoproteins of human serum. J Clin Invest. 1975;56:1622-1634.